Renaissance Technologies — Jim Simons' Legendary Quant Fund Profile
Renaissance Technologies and the Medallion Fund by Jim Simons — the best track record in history (66% avg before fees), scientists not traders, secretive culture.
13 min read- $72.62B
- 13F portfolio, Q2 2026 (3,140 positions)
- <2%
- largest single position (NVIDIA, 1.95%)
- −14.4%
- RIEF in October 2025 — worst month on record
- 1989
- Medallion's only losing year
Fact-checked against primary sources on · figures re-verified on regulator, issuer or SEC filings — not copied from other sites
Where 66% gross and 39% net come apart
Both figures are on this page. Subtract the fees from one and you do not get the other. The fields open on the numbers this page states, so the gap is visible before you change anything.
What the stated schedule actually produces
Net at this schedule: 34.16% · Net as claimed: 39%
These are different numbers. One of the three inputs above is from a different era.
Performance fee that WOULD reconcile them, at this management fee: 36.07%
Management fee that would reconcile them, at this performance fee: −3.64% — negative — so no management fee reconciles them at this performance fee. The performance fee is the figure that must have moved.
What a constant rate does over the horizon
$39,303 at the computed net (34.16%) · $140,777 at the claimed net (39%)
Two rates three decades long are not a small difference of opinion. Whichever net figure a source quotes decides the answer, which is why the source matters more than the arithmetic.
Which of these numbers comes from a document
Readers arrive here searching for the source, the official record, the audited evidence. This is the honest answer: one line of it is a filing you can open, and the returns are not.
| Claim | Value | Period | Where it comes from |
|---|---|---|---|
| 13F equity book (external funds) | $72.62B across 3,140 positions | quarter ended 2026-06-30 | FILINGSEC Form 13F-HR, accession 0001037389-26-000059, filed 2026-08-13 — the filer's own cover page (tableValueTotal / tableEntryTotal), read 2026-11-04 open the filing |
| Confidential treatment requested | none | quarter ended 2026-06-30 | FILINGisConfidentialOmitted = false on the same cover page, so the 3,140 positions are the complete reportable book and not a redacted part of one open the filing |
| Medallion average annual GROSS return | ~66% | 1988–2018 | BOOKsecondary compilations of investor letters — the figure entered print through Gregory Zuckerman, The Man Who Solved the Market (2019), and Bradford Cornell’s 2020 study of the fund. Medallion files nothing and publishes nothing, so there is no issuer to check it against. |
| Medallion average annual NET return | ~39% | 1988–2018 | BOOKthe same compilations. It is an average of annual returns after fees, not a compound growth rate, and not a figure any filing states. |
| Performance fee the 66/39 pair implies | 36.1% | the era the pair averages over | DERIVED HEREcomputed here: (66 − 5) × (1 − p) = 39. At the 5% + 44% schedule usually quoted, 66% gross is 34.2% net, and no management fee reconciles the pair at 44% — the implied one is negative. |
| Medallion 2024 return | ~+30% | calendar 2024 | PRESSpress reports, unaudited and unconfirmed by the manager. |
| Medallion's only losing year | 1989, about −4% | 1988 to date | BOOKthe same secondary compilations. 1989 is the year, so "no losing year since 1988" is wrong by one year; "since 1990" is the claim the sources support. |
What this will not tell you
- The share price of the Medallion Fund. It has no shares and no public price, so there is nothing to compute.
- A year-by-year Medallion return series. No issuer publishes one; every table in circulation is a secondary compilation, and this page will not add another.
- The Sharpe ratio. No official figure exists for a fund that reports to nobody.
Read the amounts above this way
- An average of annual returns is not a compound growth rate. Compounding a reported average overstates the result whenever the yearly figures vary — and the variance is exactly what a fund reporting to nobody does not publish. Read every amount below as "a constant rate held for N years", not as what any fund did.
- A performance fee is charged on gains, so this subtraction describes a winning year. It says nothing about what the schedule does across a run that includes losses.
Filing read at the issuer on: 2026-11-04
Track the filings yourself in FreenanceRenaissance Technologies — The Greatest Money-Making Machine in Financial History
Renaissance Technologies isn't just a hedge fund — it's a legend. Founded in 1982 by Jim Simons, a mathematician and codebreaker, Renaissance created the Medallion Fund, which holds the best investment track record in history: an average of 66% annual gross returns (before fees) across the 31 years from 1988 to 2018 — the span every published version of that figure covers.
Jim Simons, a mathematical genius who passed away in May 2024 at age 86, proved something most of Wall Street refused to believe: that financial markets contain hidden patterns, and scientists can uncover them better than traditional traders.
Quick Answer
Renaissance Technologies is the quantitative hedge fund founded in 1982 by mathematician and former NSA codebreaker Jim Simons (who died in May 2024), headquartered in East Setauket, Long Island — deliberately far from Wall Street. It hires scientists, not traders and runs systematic statistical models. Its Medallion Fund holds the best track record in history — ~66% average annual gross returns (about 39% net) with exactly one losing year in its history (1989, about −4%) — but has been closed to outsiders since 1993 and capped near $10B. The $72.62B 13F portfolio across 3,140 positions reflects the external funds (RIEF, RIDA), not Medallion — read on 4 November 2026 from the cover page of the filing itself (SEC accession 0001037389-26-000059, period 30 June 2026), which also records that no confidential treatment was requested, so those 3,140 positions are the complete reportable book. 13F filings lag 45 days and barely capture short-term quant strategies — a structural signal, not investment advice.
Key Facts
| Parameter | Value |
|---|---|
| Founder | Jim Simons (1982, passed away May 2024) |
| Investment Style | Quantitative / Systematic |
| 13F portfolio (external funds' US equities) | $72.62B across 3,140 positions (Q2 2026); regulatory AUM $96.4B (Form ADV, July 2026) |
| Number of 13F positions | 3,140 (Q2 2026) |
| Headquarters | New York (520 Madison Ave); research campus in East Setauket, Long Island |
| Latest 13F filing | August 2026 (Q2 2026) |
Investment Philosophy
Renaissance Technologies is built on a fundamental belief that financial markets, while chaotic, contain statistically detectable patterns:
- Scientists, not traders — Renaissance hires mathematicians, physicists, astronomers, statisticians, and computational linguists. It deliberately avoids hiring people from Wall Street
- Statistical models — the fund uses advanced models to identify small, repeatable patterns in market data
- Short-term trading — Medallion Fund executes thousands of trades daily, earning small amounts on each but achieving enormous cumulative returns
- Secrecy — Renaissance is one of the most secretive funds in the world. Employees sign rigorous non-disclosure agreements
- Continuous improvement — models are constantly refined based on new data
Who Was Jim Simons?
James Harris Simons (1938-2024) was one of the most extraordinary minds of the 20th and 21st centuries — a mathematician, cryptologist, entrepreneur, and philanthropist.
Key Facts About Jim Simons:
- Mathematical achievements: created the Chern-Simons invariants (with Shiing-Shen Chern), fundamental to differential geometry and theoretical physics
- Codebreaking: worked for the NSA (National Security Agency) as a cryptologist during the Cold War
- Academic career: chairman of the mathematics department at Stony Brook University
- Net worth: estimated at $31.4 billion at the time of his death (2024)
- Death: passed away on May 10, 2024, at age 86
- Philanthropy: with his wife Marilyn, founded the Simons Foundation, donating billions to science and education
- Famous quote: "In God we trust. All others must bring data."
The Medallion Fund — The Holy Grail of Investing
The Medallion Fund is Renaissance Technologies' flagship fund and an absolute industry legend:
Medallion Fund Performance:
- Average annual gross return: ~66% (before fees)
- Average annual net return: ~39% (after 5% management + 44% performance fees)
- Period: 1988–2018, 31 years — the span the published averages cover
- Stated fee schedule: 5% of assets + 44% of gains
- The two figures do not reconcile at that schedule: (66% − 5%) × (1 − 0.44) = 34.2% net, not 39%. The performance fee that turns 66% into 39% at a 5% management fee is 36.1% — and at a 44% performance fee the implied management fee is negative, so no management fee reconciles them. The 66/39 pair averages over an era in which the performance fee was lower than the 44% quoted today. The tool above does this subtraction on whichever figures you enter.
- Cumulative profits: over $100 billion in profits since inception
- Only losing year: 1989 (about −4%); no losing year since 1990
What Makes Medallion Unique:
- Closed since 1993: the fund is exclusively available to current and former Renaissance employees
- Capped size: AUM deliberately maintained at ~$10 billion — excess is returned to investors
- Fees: 5% management fee + 44% performance fee — the highest in the industry, yet net returns are still legendary
- Compounding, with the assumption named: $1 held for 36 years at a constant 39% is about $140,800; at the 34.2% the stated 5% + 44% schedule actually produces, it is about $39,300. Both are arithmetic on a constant rate, not a record of what the fund did — an average of annual returns is not a compound growth rate, and compounding one overstates the result whenever the yearly figures vary.
For Perspective:
- S&P 500: ~$1 → ~$40 over the same period
- Warren Buffett (Berkshire Hathaway): ~$1 → ~$150
- Medallion Fund (net): the figure depends entirely on which net rate the source quotes — see the two amounts above, which differ by 3.6x over the same 36 years
External Funds vs. Medallion
Renaissance also manages funds available to outside investors:
Renaissance Institutional Equities Fund (RIEF):
- Available to institutional investors
- Results significantly worse than Medallion
- Average annual return: ~10-12%
- AUM: RIEF just under $20B and RIDA ~$2.8B (late 2025) — the external funds are what the $72.6B 13F portfolio reflects
Renaissance Institutional Diversified Alpha (RIDA):
- Long/short strategy
- Mixed results, sometimes disappointing
The Key Difference:
There is a chasm between Medallion's performance (available only to insiders) and the external funds. This is one of the most controversial aspects of Renaissance — the best strategies are reserved exclusively for employees.
Culture of Secrecy
Renaissance Technologies is one of the most secretive funds in the world:
- NDAs: employees sign some of the most restrictive non-disclosure agreements in the industry
- Location: headquartered in East Setauket on Long Island — deliberately far from Wall Street
- No media: Renaissance virtually never gives interviews or media commentary
- Hiring process: seeks exceptional scientists, not finance professionals. Astronomers, computational linguists, mathematicians
- Academic culture: weekly scientific seminars, university-like atmosphere
Savings in one bank, investments in another? See it all in one place — and how many months it could carry you.
See your Freedom Runway — freeTop 13F Holdings (Q2 2026)
Source: SEC Form 13F-HR filed August 2026 (period ending June 30, 2026) — $72.62B across 3,140 positions, no options. Renaissance's book is famously flat: no position exceeds 2%.
| Holding | Sector | Value (Q2 2026) | % of 13F |
|---|---|---|---|
| NVIDIA | Semiconductors/AI | $1.42B | 1.95% |
| Alphabet | Internet/AI | $1.38B | 1.91% |
| Meta Platforms | Internet | $1.14B | 1.57% |
| Intel | Semiconductors | $1.02B | 1.41% |
| United Therapeutics | Biotech | $0.93B | 1.27% |
| Palantir | Software/AI | $0.88B | 1.22% |
| Exelixis | Biotech | $0.73B | 1.01% |
| VeriSign | Internet infrastructure | $0.62B | 0.85% |
For reference, Palantir was the #1 position at end-2025 ($1.56B, 2.4%); Apple is not held and Microsoft was exited in 2026.
What changed in 2025-26
- October 2025 "quant quake": RIEF fell 14.4% and RIDA 15.6% in a single month — the worst month on record for the external funds — before a +12.6% November rebound; RIEF finished 2025 around +9.6% (secondary reporting) after +22.7% in 2024.
- Shrinking external assets: RIEF is now just under $20B, roughly half its size five years ago; RIDA ~$2.8B.
- Medallion: reported roughly +30% in 2024 (press, unofficial); the fund remains closed to outsiders.
History and Key Moments
1982 — Founding
Jim Simons founded Monemetrics (later Renaissance Technologies) after leaving academia. The firm initially traded currencies.
1988 — Birth of Medallion
Launch of the Medallion Fund, initially focused on futures markets. The first years were rocky, but after model recalibration, results became legendary.
1993 — Medallion Closes
Medallion was closed to outside investors. From this point forward, it was available only to Renaissance employees.
2000-2010 — The Golden Decade
Medallion generated spectacular returns regardless of market conditions. In 2008, when most funds were losing money, Medallion earned +82%.
2005-2012 — External Funds Launch (RIEF 2005, RIDA/RIDGE 2012)
Renaissance launched RIEF and RIDA, opening to outside investors but with different (inferior) strategies than Medallion.
2021 — Tax Controversy
Renaissance paid $7 billion to settle with the IRS over controversial tax strategies related to the Medallion Fund.
2024 — Jim Simons' Passing
Jim Simons passed away on May 10, 2024. His death closed an era, but Renaissance continues operating under CEO Peter Brown.
Fund Performance
Medallion Fund (employees only):
- Average annual gross return: ~66%
- Average annual net return: ~39%
- Best year: 2000: +98.5% (net)
- 2008 (crisis): +82% (net, per the Zuckerman series)
- No losing year since 1990 (Medallion's only loss: ~−4% in 1989)
External Funds (RIEF, RIDA):
- RIEF average annual return: ~10-12%
- RIDA: more variable results
- Significantly worse than Medallion
What This Means for Individual Investors
Renaissance Technologies offers fascinating lessons:
- Data beats intuition — Renaissance's success proves that a systematic, data-driven approach can deliver spectacular results
- The 13F portfolio is not Medallion — when analyzing the 13F portfolio, you're seeing the external funds, not the legendary Medallion
- Humility — even the best fund in history keeps Medallion's AUM low because it knows strategies have limited capacity
- New positions — Renaissance entering a new stock can signal interesting trends; in the Q2 2026 book the biggest healthcare names are United Therapeutics and Exelixis
- Data lag — 13F data has a 45-day delay and doesn't capture short-term strategies
How to Analyze Renaissance's Portfolio
- It's not Medallion — the most important rule: the 13F portfolio reflects external funds (RIEF, RIDA), not the legendary Medallion
- Pharmaceutical positions — the healthcare tilt is real and visible in the filing: United Therapeutics (1.27%) and Exelixis (1.01%) are both in the Q2 2026 top ten
- Cross-quant comparison — compare with Two Sigma and D.E. Shaw to see quantitative consensus
- Sector rotation — changes in sector allocation may signal broader trends
- New entries — a new position in Renaissance's portfolio can be an interesting signal
The Simons Foundation — A Scientific Legacy
Jim Simons and his wife Marilyn created one of the world's largest private scientific foundations:
- Annual budget: over $500 million for scientific research
- Flatiron Institute: a research center in New York focusing on computational astrophysics, biology, mathematics, and neuroscience
- Math for America: a program supporting public school math teachers
- Autism research: one of the largest private sponsors of autism research
- Simons Observatory: an astronomical observatory in Chile
Simons' legacy extends far beyond Wall Street — his scientific philanthropy is comparable to Howard Hughes or Alfred Sloan.
Controversies and Challenges
IRS Tax Settlement (2021)
Renaissance paid $7 billion to settle with the IRS. The controversy centered on how the Medallion Fund used basket options to convert short-term gains into long-term gains, reducing the tax burden.
The Gap Between Funds
The fact that the best strategies (Medallion) are reserved exclusively for employees is controversial. External investors pay for the Renaissance brand but receive significantly worse results.
Robert Mercer and Politics
Robert Mercer, Renaissance co-CEO (until 2017), generated controversy with his political involvement, including funding Donald Trump's campaign and Cambridge Analytica. Mercer eventually stepped down as co-CEO under media pressure.
Renaissance by the Numbers
- Year founded: 1982 (as Monemetrics)
- Medallion profits since inception: over $100 billion
- Medallion fees: 5% + 44% (highest in the industry)
- Employees: ~300 (far fewer than competitors)
- Headquarters: East Setauket, Long Island (deliberately outside Wall Street)
- Medallion's only loss: 1989 (~−4%)
Important Caveat
Renaissance's 13F report mainly reflects the external funds. The Medallion Fund, with its ultra-rapid turnover, is virtually invisible in quarterly reports.
Track Renaissance Technologies' portfolio alongside other legendary funds with Freenance
Common Questions
Why is the Medallion Fund considered the best fund in history?
The Medallion Fund averaged 66% annual gross returns (about 39% net) over the 31 years from 1988 to 2018, with one losing year in its history — 1989, down about 4%. No other fund in history has come close to such results over such a long period.
Can I invest in the Medallion Fund?
No. The Medallion Fund has been closed since 1993 and is available exclusively to current and former Renaissance Technologies employees. External funds (RIEF, RIDA) are available to institutional investors but have significantly worse performance.
Who was Jim Simons?
Jim Simons (1938-2024) was a mathematician, NSA cryptologist, and founder of Renaissance Technologies. He created the Medallion Fund and proved that scientists could beat Wall Street. His net worth at the time of death was estimated at $31.4 billion.
Why does Renaissance hire scientists instead of traders?
Renaissance believes that financial markets contain statistically detectable patterns best uncovered by scientists — mathematicians, physicists, and computer scientists. It deliberately avoids hiring people with Wall Street experience to avoid traditional investment biases.
Why do Renaissance's external funds perform worse than Medallion?
Medallion uses short-term strategies with limited capacity — that's why AUM is deliberately kept low (~$10B). External funds have larger AUM and use different, less aggressive strategies, resulting in lower (though still solid) returns.
What is Renaissance's future after Jim Simons' passing?
Renaissance is managed by Peter Brown, who took over CEO duties while Simons was still alive. The firm is built on systems and processes, not on one person — but losing a visionary of Simons' caliber is undeniably a significant loss.
How did the Medallion Fund perform during crises?
The Medallion Fund showed remarkable resilience during crises: in 2000 (dot-com bust) it earned +98.5%, in 2008 (global financial crisis) it earned +82%, and in 2020 (COVID-19 pandemic) it also generated high returns. Short-term strategies and lack of exposure to specific market theses allow Medallion to profit from volatility.
How many people work at Renaissance Technologies?
Renaissance employs approximately 300 people — far fewer than competitors like Citadel (4,000+) or Millennium (5,000+). A small, elite team consisting mainly of scientists is a key element of the firm's culture.
- Citadel Advisors — Ken Griffin's Multi-Strategy Fund Profile
- Millennium Management — Israel Englander's Pod Model Fund Profile
- D.E. Shaw & Co — David Shaw's Quantitative Fund Profile
- Two Sigma Investments — Data Science Driven Quant Fund Profile
- Berkshire Hathaway — Warren Buffett's Fund Profile & 13F Portfolio
FAQ
What style does Renaissance Technologies use?
Renaissance is the original scientist-run quant fund, founded by mathematician Jim Simons in 1982 and built around statistical models rather than discretionary traders. The legendary Medallion Fund — closed to outsiders since 1993 — runs ultra-short-term systematic strategies, while external funds (RIEF, RIDA) use slower, capacity-friendly approaches.
How big is Renaissance's 13F portfolio?
The 13F equity portfolio is $72.62B across 3,140 positions (SEC accession 0001037389-26-000059, period 30 June 2026, filed 13 August 2026), but this reflects the external funds, not Medallion. Medallion's holding periods are too short and its AUM is deliberately capped at ~$10B, so it largely does not show up in quarterly 13F snapshots.
What are Renaissance's main 13F positions?
From the Q2 2026 filing itself, the ten largest are NVIDIA (1.95% of the book), Meta Platforms (1.57%), Intel (1.41%), United Therapeutics (1.27%), Palantir (1.22%), Alphabet (1.14%), Exelixis (1.01%), VeriSign (0.85%), Kinross Gold (0.80%) and CrowdStrike (0.79%). The whole top ten is 12.0% of a 3,140-position book, which is what "famously flat" means in a number: no single name reaches 2%, and the generic mega-cap list this answer used to carry named four companies that are not in the filing's top ten at all.
Why does the 45-day 13F lag matter for a quant fund?
US 13F filings appear up to 45 days after quarter-end. For a quant book that trades on signals lasting days or hours, the published snapshot is essentially archaeology — useful for studying structure and sector tilts, not for copying live trades.
How can I follow Renaissance with Freenance Smart Money?
Freenance's Smart Money module aggregates SEC 13F filings so you can track Renaissance's reported external-fund equity portfolio over time, see new entries and exits, and compare it with other quants like Two Sigma and D.E. Shaw. The content is research and education only — Freenance is not a broker or licensed advisor under KNF, and Medallion's strategies are not investable.